Can You Advertise Botox in Australia? The TGA Rule, Explained

No, you cannot advertise Botox in Australia. Botox is a brand name for botulinum toxin, a prescription-only (Schedule 4) medicine. The law bans ads for prescription medicines to the public. So you cannot name the product, and you cannot use phrases that point to it, like "anti-wrinkle injections". You can still advertise that your clinic offers consultations. You can name your practitioner and their qualifications, and explain what happens at an appointment. You cannot name the medicine, promise a result or use testimonials.

Why is Botox banned from advertising?

You cannot advertise Botox in Australia. Botox is a brand name for botulinum toxin, and that is a prescription-only medicine. The Therapeutic Goods Act is the law that covers medicines. It bans ads for prescription medicines to the public. The ban covers the brand name and any clear hint at it.

Here is the detail. The medicine inside Botox is botulinum toxin. In Australia it sits in Schedule 4 of the Poisons Standard. That simply means you need a prescription for it.

The rules come from the Therapeutic Goods Act 1989 and the Therapeutic Goods Advertising Code. The Therapeutic Goods Administration (TGA) is the body that runs these rules. It says you cannot advertise a prescription medicine to the public. The ban is wide. It covers the brand name, the active ingredient and anything that clearly refers to the product.

The thinking behind it is simple. A health professional should choose a prescription medicine for each patient. The law does not want ads to push the public toward a prescription product. Botulinum toxin is a prescription medicine, so the same ban applies to it.

Which words are caught by the ban?

This is where most clinics slip. They know "Botox" is risky, so they reach for a softer phrase. But the softer phrase still points to the same medicine, so it is caught too. The TGA has guidance on ads for cosmetic injectables, and it is clear on this. Your ad must not refer to botulinum toxin in any way. That includes an indirect phrase that a reader would take to mean the medicine.

In the clinic sites I audit, the word "Botox" itself is rarely the problem. The usual slip is a softer stand-in, like "anti-wrinkle injections". It sits in a page heading, a button or a meta description (the short summary Google shows). The clinic forgot that text was public.

• Brand names. This means Botox, Dysport, Xeomin and any other botulinum toxin brand.
• The ingredient. This means botulinum toxin, or "botulinum".
• Common stand-ins. These include "Anti-wrinkle injections", "anti-wrinkle treatment", "wrinkle relaxers", "muscle relaxant injections" and "tox". The TGA reads these as references to the prescription medicine.
• Codes and emojis. A single letter, a needle emoji or a hashtag can stand for the product. Dressing it up does not change what it points to.
• Prices and offers for the product. Lines like "$X per area" or "units from $Y" name a prescription treatment by its price. That still counts as an ad for the medicine.

So the exact word does not decide it. Ask yourself one question instead. Would a reasonable person read it as the prescription medicine? If yes, it is caught.

What can a cosmetic clinic say instead?

The ban limits what you can name. You are still free to market your clinic. You can build a clear, honest page that brings in enquiries.

• That you offer consultations. You can say your clinic offers cosmetic injectable consultations, or appointments to talk about treatment options.
• Who provides them. You can name the practitioner, their role and their real qualifications in plain words.
• What happens at an appointment. You can describe the check-up, the questions you ask, the consent process and aftercare. Just leave out any promise.
• Factual practice details. You can share your location, hours, access and how to book.
• General education, as long as it does not promote one prescription medicine or work as an ad for it.

You move from selling a product to offering a chat with a professional. That approach is within the rules, and it suits your patients too. Someone choosing an injector cares more about the person holding the needle than the brand in the vial.

Say this, not that: five injectable rewrites

Here are 5 lines that break the rules, each with a safe version. Every "say this" line meets both the TGA and AHPRA rules at once.

The two layers: TGA and AHPRA

Cosmetic injectables are unusual. Two sets of rules apply to the same page at the same time.

The TGA layer is about the medicine. Botulinum toxin is a prescription medicine, so you cannot advertise it to the public. This layer bans the brand names and the stand-in phrases.

The AHPRA layer is about the practitioner. AHPRA is the body behind the health ad rules for registered practitioners. If a registered nurse, doctor or dentist does the treatment, the AHPRA advertising guidelines apply to how they promote it. This layer bans testimonials about care, claims about results and boasts like calling yourself the top clinic. It also bans freebies or discounts used to lure people in. If these rules are new to you, start with the main guide on what your clinic can and cannot say under AHPRA. Then read the guide just for cosmetic clinics.

Dermal fillers work a little differently. Most fillers count as medical devices. They are not prescription medicines, so the prescription ban does not catch them in the same way. The Advertising Code and the AHPRA rules still apply, though. You still cannot promise results or use testimonials. When you advertise injectables in general, the safe path is simple. Write to the stricter rule and do not name any product.

What happens if you get it wrong?

An ad for a prescription medicine to the public breaks the Therapeutic Goods Act. The TGA can send you a warning or a fine notice, or take you to court. As of June 2026, the top penalties for serious ad offences run to thousands of penalty units. For a person that is more than $1.5 million per offence. A company can face several times that.

There is a second risk on top of that. If a registered practitioner is involved, anyone can report the ad to AHPRA. That could be a member of the public or a competitor. It is a separate process, and it can affect the practitioner's registration.

You can check most of this yourself. Open every page, ad and social profile. Then ask yourself 3 questions. Does it name or hint at the medicine? Does it promise a result? Does it use a patient's words? If any answer is yes, that page needs a rewrite.

This is general guidance for clinic owners and marketers. It is not legal advice. The TGA and AHPRA update their guidance from time to time. Check the current versions, and get formal advice for pages where a lot is at stake.